These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 18729849
1. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder. Vermeersch P, Van Hoovels L, Delforge M, Mariën G, Bossuyt X. Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849 [Abstract] [Full Text] [Related]
2. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI. Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [Abstract] [Full Text] [Related]
3. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F, Thiry C, Willems D. Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [Abstract] [Full Text] [Related]
4. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G. BMC Nephrol; 2008 Sep 22; 9():11. PubMed ID: 18808676 [Abstract] [Full Text] [Related]
5. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Beetham R, Wassell J, Wallage MJ, Whiteway AJ, James JA. Ann Clin Biochem; 2007 Nov 22; 44(Pt 6):516-22. PubMed ID: 17961305 [Abstract] [Full Text] [Related]
6. [Detection of free light chains--a new method of diagnostics of haematological diseases]. Mecl J, Benáková H, Nohejlová A, Straub J, Zima T, Spicka I. Cas Lek Cesk; 2007 Nov 22; 146(2):159-62. PubMed ID: 17373113 [Abstract] [Full Text] [Related]
7. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma. Nowrousian MR, Brandhorst D, Sammet C, Kellert M, Daniels R, Schuett P, Poser M, Mueller S, Ebeling P, Welt A, Bradwell AR, Buttkereit U, Opalka B, Flasshove M, Moritz T, Seeber S. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8706-14. PubMed ID: 16361557 [Abstract] [Full Text] [Related]
8. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]. Shimazaki C, Murakami H, Sawamura M, Matsuda M, Kinoshita T, Hata H, Sugiura I, Tsushita K, Nagura E, Kosugi H, Itoh J, Shimizu K. Rinsho Ketsueki; 2010 Apr 15; 51(4):245-52. PubMed ID: 20467220 [Abstract] [Full Text] [Related]
9. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M, Lazăr V, Coriu D. Roum Arch Microbiol Immunol; 2011 Apr 15; 70(1):15-22. PubMed ID: 21717807 [Abstract] [Full Text] [Related]
10. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect. Shaheen SP, Levinson SS. Clin Chim Acta; 2009 Aug 15; 406(1-2):162-6. PubMed ID: 19410572 [Abstract] [Full Text] [Related]
11. The evolving use of serum free light chain assays in haematology. Pratt G. Br J Haematol; 2008 May 15; 141(4):413-22. PubMed ID: 18318757 [Abstract] [Full Text] [Related]
12. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance]. Li C, Wen YB, Li H, Su W, Li J, Cai JF, Chen LM, Li XM, Li XW. Zhonghua Yi Xue Za Zhi; 2017 Aug 08; 97(30):2344-2348. PubMed ID: 28822451 [Abstract] [Full Text] [Related]
13. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT. J Immunol Methods; 2013 May 31; 391(1-2):1-13. PubMed ID: 23388695 [Abstract] [Full Text] [Related]
14. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, Larson DR, Plevak MF, Katzmann JA. Br J Haematol; 2004 Nov 31; 127(3):308-10. PubMed ID: 15491291 [Abstract] [Full Text] [Related]
15. [Serum free light chains for diagnosis and follow-up of multiple myeloma]. Jung S, Kim M, Lim J, Kim Y, Han K, Min CK, Min WS. Korean J Lab Med; 2008 Jun 31; 28(3):169-73. PubMed ID: 18594166 [Abstract] [Full Text] [Related]
16. Serum free light chains in clinical laboratory diagnostics. Jenner E. Clin Chim Acta; 2014 Jan 01; 427():15-20. PubMed ID: 23999048 [Abstract] [Full Text] [Related]
17. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X. Clin Chim Acta; 2009 Dec 01; 410(1-2):54-8. PubMed ID: 19778527 [Abstract] [Full Text] [Related]
18. Monoclonal gammopathy in a tertiary referral hospital. Tamimi W, Alaskar A, Alassiri M, Alsaeed W, Alarifi SA, Alenzi FQ, Jawdat D. Clin Biochem; 2010 Jun 01; 43(9):709-13. PubMed ID: 20206156 [Abstract] [Full Text] [Related]
19. Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples. Levinson SS. Clin Chim Acta; 2011 Nov 20; 412(23-24):2206-10. PubMed ID: 21864518 [Abstract] [Full Text] [Related]
20. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM, Katzmann JA, Bradwell A, Kay NE, Witzig TE. Transl Res; 2007 Apr 20; 149(4):231-5. PubMed ID: 17383597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]